Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research)

Market growth is driven by factors such as the rising geriatric population and the increasing prevalence of chronic & lifestyle diseases, growing adoption of Point-of-Care testing devices and rising demand for laboratory automation. On the other hand, high capital investment, shortage of clinical laboratory technicians, and the availability of refurbished products is expected to limit market growth to a certain extent in the coming years.

The reagents accounted for the highest growth rate in the clinical chemistry analyzers market, by product, during the forecast period

The clinical chemistry analyzers market is segmented into analyzers, reagents and other products. The reagents segment accounted for the highest growth rate in the clinical chemistry analyzers market in 2020. The requirement reagents in large numbers compared to analyzers is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of reagents compared to analyzers.

Lipid profile tests segment accounted for the highest CAGR

Based on the test type, the clinical chemistry analyzers market is segmented basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2020, the lipid profile tests segment accounted for the highest growth rate. Rapid growth in obesity rates and the increasing incidence of obesity-related diseases are the major factors driving this segment's growth.

Hospitals and clinics segment accounted for the highest CAGR

Based on end-users, the clinical chemistry analyzers market is segmented into hospitals and clinics, diagnostic laboratories, research laboratories & institutes, and other end users. In 2020, the hospitals and clinics segment accounted for the highest growth rate. This can be attributed to increasing number of hospitals worldwide owing to the increasing incidences of diseases & disorders, increasing adoption of analyzers and rising technological advancements.

Asia Pacific: The fastest-growing region clinical chemistry analyzers market

The global clinical chemistry analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, high burden of chronic diseases, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinicsare driving the growth of the clinical chemistry analyzers market in this region.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
By Designation: C-level - 30%, D-level - 20%, and Others - 50%
By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Latin America - 9% , and the Middle East & Africa - 3%

Lits of Companies Profiled in the Report:

F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
Abbott Laboratories (US)
Thermo Fisher Scientific Inc. (US)
Siemens AG (Germany)
HORIBA Ltd. (Japan)
Sysmex Corporation (Japan)
HITACHI (Japan)
EKF Diagnostics (UK)
Ortho Clinical Diagnostics (US)
ELITech Group (France)
Mindray Medical International Ltd. (China)
BIOBASE Group (China)
SFRI Medical Diagnostics (France)
Trivitron Healthcare Pvt. Ltd. (India)
Randox Laboratories Ltd. (UK)
Medica Corporation (US)
Meril Life Sciences Pvt. Ltd. (India)
Erba Mannheim (UK)
Genrui Biotech Inc. (China)
DIRUI Industrial Co. Ltd. (China)
Teco Diagnostics (US)
Balio Diagnostics (France)
Snibe Co. Ltd. (China)
AMS Alliance (Italy)

Research Coverage:

This report provides a detailed picture of the global clinical chemistry analyzers market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical chemistry analyzers market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
Figure 1 Inclusions & Exclusions
1.2.1 Markets Covered
Figure 2 Clinical Chemistry Analyzers Market
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 3 Clinical Chemistry Analyzers Market: Research Design Methodology
2.2.1 Secondary Data
2.2.1.1 Key Data from Secondary Sources
2.2.2 Primary Data
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2.2.1 Key Data from Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
Figure 5 Clinical Chemistry Analyzers Market: Bottom-Up Approach
2.3.2 Top-Down Approach
Figure 6 Clinical Chemistry Analyzer Market: Top-Down Approach
2.4 Market Breakdown and Data Triangulation
Figure 7 Data Triangulation Methodology
2.5 Assumptions for the Study

3 Executive Summary
Figure 8 Clinical Chemistry Analyzers Market, by Product, 2021 Vs. 2026 (USD Million)
Figure 9 Clinical Chemistry Analyzers Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 10 Clinical Chemistry Analyzers Market, by Test Type, 2021 Vs. 2026 (USD Million)
Figure 11 Clinical Chemistry Analyzers Market, by End-user, 2021 Vs. 2026 (USD Million)
Figure 12 Clinical Chemistry Analyzers Market, by Region, 2021 Vs. 2026 (USD Million)

4 Premium Insights
4.1 Clinical Chemistry Analyzers Market Overview
Figure 13 the Rising Adoption of Poc Products is Expected to Support Market Growth During the Forecast Period
4.2 Clinical Chemistry Analyzers Market, by Product, 2021 Vs. 2026 (USD Million)
Figure 14 the Reagents Segment is Expected to Command the Largest Share of the Market, by Product, in 2021
4.3 Clinical Chemistry Analyzers Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 15 the Semi-Automatic Analyzer Segment is Expected to Hold the Largest Share of the Market, by Type, During the Forecast Period
4.4 Clinical Chemistry Analyzers Market, by Region, 2021 Vs. 2026
Figure 16 the Asia-Pacific Market is Estimated to Grow at the Highest CAGR During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 17 Clinical Chemistry Analyzer Market: Drivers, Restraints, Opportunities, and Trends
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population and the Increasing Prevalence of Chronic & Lifestyle Diseases
Table 1 Estimated Increase in the Geriatric Population, by Region (2019-2050)
5.2.1.2 Growing Adoption of Point-Of-Care Testing Devices
5.2.1.3 Increasing Demand for Laboratory Automation
5.2.2 Restraints
5.2.2.1 the Requirement of High Capital Investments and a Shortage of Skilled Laboratory Technicians
5.2.2.2 Availability of Refurbished Analyzers
5.2.3 Opportunities
5.2.3.1 Increasing Government Initiatives and Funding for Preventive Care
5.2.4 Trends
5.2.4.1 Multichannel Operations of Integrated Analyzers
5.2.5 Covid 19 Impact Analysis
5.3 Pricing Analysis
Table 2 Average Selling Prices of Products (USD)
5.4 Value Chain Analysis
Figure 18 Value Chain Analysis of the Clinical Chemistry Analyzers Market
5.5 Supply Chain Analysis
Figure 19 Supply Chain Analysis
5.6 Ecosystem Analysis
5.7 Porter’s Five Forces Analysis
Figure 20 Porter’s Five Forces Analysis
5.7.1 Threat from New Entrants
5.7.2 Threat from Substitutes
5.7.3 Bargaining Power of Buyers
5.7.4 Bargaining Power of Suppliers
5.7.5 Competitive Rivalry Among Existing Players
5.8 PESTLE Analysis

6 Clinical Chemistry Analyzers Market, by Product
6.1 Introduction
Table 3 Clinical Chemistry Reagents Market, by Product, 2019-2026 (USD Million)
6.2 Reagents
6.2.1 The Recurrent Purchase Requirement of Reagents Drives Market Growth
Table 4 Clinical Chemistry Reagents Market, by Region, 2019-2026 (USD Million)
6.3 Analyzers
Table 5 Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 6 Clinical Chemistry Analyzers Market, by Region, 2019-2026 (USD Million)
6.3.1 Semi-Automatic Analyzers
6.3.1.1 The Cost-Effectiveness of Semi-Automatic Analyzers Drives Segment Growth
Table 7 Semi-Automatic Analyzers Market, by Region, 2019-2026 (USD Million)
6.3.2 Fully Automatic Analyzers
6.3.2.1 Fully Automatic Analyzers Offer Rapid Sample Processing, Thus Enhancing Workflows
Table 8 Fully Automatic Analyzers Market, by Region, 2019-2026 (USD Million)
6.3.3 Point-Of-Care Analyzers
6.3.3.1 The Increasing Adoption of Poc Technologies Drives Segment Growth
Table 9 Point-Of-Care Analyzers Market, by Region, 2019-2026 (USD Million)
6.4 Other Products
Table 10 Clinical Chemistry Analyzers for Other Products Market, by Region, 2019-2026 (USD Million)

7 Clinical Chemistry Analyzers Market, by Test Type
7.1 Introduction
Table 11 Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
7.2 Basic Metabolic Panel
7.2.1 The Rising Incidence of Diabetes and Other Chronic Diseases is a Primary Growth Driver for this Segment
Table 12 Basic Metabolic Panel Tests Market, by Region, 2019-2026 (USD Million)
7.3 Liver Panel
7.3.1 The Increasing Incidence of Liver-Related Diseases is a Key Factor Driving Market Growth
Table 13 Liver Panel Tests Market, by Region, 2019-2026 (USD Million)
7.4 Renal Profile
7.4.1 The Rising Incidence of ESRD Patients Drives the Growth of the Renal Profile Testing Market
Table 14 Renal Profile Tests Market, by Region, 2019-2026 (USD Million)
7.5 Lipid Profile
7.5.1 Lipid Profile Tests Are Prescribed to Monitor Unhealthy Lipid Levels and Avoid CVD Risks
Table 15 Lipid Profile Tests Market, by Region, 2019-2026 (USD Million)
7.6 Thyroid Function Panel
7.6.1 The Increasing Incidence of Thyroid-Related Disorders Drives the Growth of this Segment
Table 16 Thyroid Function Panel Tests Market, by Region, 2019-2026 (USD Million)
7.7 Electrolyte Panel
7.7.1 The Electrolyte Test Panel is Prescribed to Patients That Suffer from Hypertension or Liver & Kidney Diseases
Table 17 Electrolyte Panel Tests Market, by Region, 2019-2026 (USD Million)
7.8 Specialty Chemical Tests
7.8.1 This Segment is Expected to Grow at the Lowest CAGR During the Forecast Period as These Tests Are Not Prescribed Regularly
Table 18 Specialty Chemical Tests Market, by Region, 2019-2026 (USD Million)

8 Clinical Chemistry Analyzers Market, by End-user
8.1 Introduction
Table 19 Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
8.2 Hospitals and Clinics
8.2.1 Hospitals are the Major End-users of Clinical Chemistry Analyzers
Table 20 Clinical Chemistry Analyzers Market for Hospitals and Clinics, By Region, 2019-2026 (USD Million)
8.3 Diagnostic Laboratories
8.3.1 Increasing Outsourcing Activities to Diagnostic Laboratories for Reduced Costs Drive the Growth of this Segment
Table 21 Clinical Chemistry Analyzers Market for Diagnostic Laboratories, by Region, 2019-2026 (USD Million)
8.4 Research Laboratories & Institutes
8.4.1 Growth in Funding for Life Science Research is a Primary Driver for this End-User Segment
Table 22 Clinical Chemistry Analyzers Market for Research Laboratories & Institutes, by Region, 2019-2026 (USD Million)
8.5 Other End-users
Table 23 Clinical Chemistry Analyzers Market for Other End-users, by Region, 2019-2026 (USD Million)

9 Clinical Chemistry Analyzers Market, by Region
9.1 Introduction
Table 24 Clinical Chemistry Analyzers Market, by Region, 2019-2026 (USD Million)
9.2 North America
Figure 21 North America: Clinical Chemistry Analyzers Market Snapshot
Table 25 North America: Clinical Chemistry Analyzers Market, by Country, 2019-2026 (USD Million)
Table 26 North America: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 27 North America: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 28 North America: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 29 North America: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.2.1 US
9.2.1.1 Increasing Cases of Diabetes & Obesity-Related Diseases is a Key Factor Expected to Drive Market Growth
Table 30 Us: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 31 Us: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 32 Us: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 33 Us: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.2.2 Canada
9.2.2.1 the Increasing Prevalence of Chronic & Lifestyle Diseases Drives the Market Growth in Canada
Table 34 Canada: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 35 Canada: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 36 Canada: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 37 Canada: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3 Europe
Table 38 Europe: Clinical Chemistry Analyzers Market, by Country,2019-2026 (USD Million)
Table 39 Europe: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 40 Europe: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 41 Europe: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 42 Europe: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.1 UK
9.3.1.1 The Increasing Number of Accredited Clinical Laboratories in the UK Propels Market Growth for Chemical Analyzers
Table 43 Uk: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 44 Uk: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 45 Uk: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 46 Uk: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.2 Germany
9.3.2.1 Increasing Healthcare Expenditure to Drive Market Growth in Germany
Table 47 Germany: Clinical Chemistry Analyzers Market, by Product,2019-2026 (USD Million)
Table 48 Germany: Clinical Chemistry Analyzers Market, by Type,2019-2026 (USD Million)
Table 49 Germany: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 50 Germany: Clinical Chemistry Analyzers Market, by End-user,2019-2026 (USD Million)
9.3.3 France
9.3.3.1 Rising R&D Expenditure in France to Drive Market Growth
Table 51 France: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 52 France: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 53 France: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 54 France: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.4 Italy
9.3.4.1 Age-Related Chronic Conditions Owing to a Large Geriatric Population to Drive Market Growth in Italy
Table 55 Italy: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 56 Italy: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 57 Italy: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 58 Italy: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.5 Spain
9.3.5.1 Increasing Prevalence of Age-Associated Disorders to Drive Market Growth in Spain
Table 59 Spain: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 60 Spain: Clinical Chemistry Analyzers Market, by Type,2019-2026 (USD Million)
Table 61 Spain: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 62 Spain: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.6 Russia
9.3.6.1 Increasing Access to Quality Healthcare Will Support Market Growth in Russia
Table 63 Russia: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 64 Russia: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 65 Russia: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 66 Russia: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.3.7 Rest of Europe (RoE)
Table 67 RoE: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 68 RoE: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 69 RoE: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 70 RoE: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.4 Asia-Pacific
Figure 22 APAC: Clinical Chemistry Analyzers Market Snapshot
Table 71 APAC: Clinical Chemistry Analyzers Market, by Country, 2019-2026 (USD Million)
Table 72 APAC: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 73 APAC: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 74 APAC: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 75 APAC: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.4.1 China
9.4.1.1 China Accounted for the Largest Share of the APAC Market in 2020
Table 76 China: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 77 China: Clinical Chemistry Analyzers Market, by Type,2019-2026 (USD Million)
Table 78 China: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 79 China: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.4.2 Japan
9.4.2.1 A Favorable Regulatory Framework to Drive Market Growth in Japan
Table 80 Japan: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 81 Japan: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 82 Japan: Clinical Chemistry Analyzers Market, by Test Type,2019-2026 (USD Million)
Table 83 Japan: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.4.3 India
9.4.3.1 Increasing Private & Public Investments in the Country’S Healthcare System Will Drive Market Growth
Table 84 India: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 85 India: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 86 India: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 87 India: Clinical Chemistry Analyzers Market, by End-user,2019-2026 (USD Million)
9.4.4 Rest of Asia-Pacific (Roapac)
Table 88 Roapac: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 89 Roapac: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 90 Roapac: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 91 Roapac: Clinical Chemistry Analyzers Market, by End-user,2019-2026 (USD Million)
9.5 Latin America
Table 92 Latin America: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 93 Latin America: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 94 Latin America: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 95 Latin America: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)
9.6 Middle East and Africa
Table 96 MEA: Clinical Chemistry Analyzers Market, by Product, 2019-2026 (USD Million)
Table 97 MEA: Clinical Chemistry Analyzers Market, by Type, 2019-2026 (USD Million)
Table 98 MEA: Clinical Chemistry Analyzers Market, by Test Type, 2019-2026 (USD Million)
Table 99 MEA: Clinical Chemistry Analyzers Market, by End-user, 2019-2026 (USD Million)

10 Competitive Landscape
10.1 Overview
Figure 23 Key Developments in the Clinical Chemistry Analyzers Market
10.2 Market Share Analysis
Figure 24 Clinical Chemistry Analyzers Market Share, by Key Player (2019)
10.3 Company Evaluation Quadrant
10.3.1 List of Evaluated Vendors
10.3.2 Stars
10.3.3 Emerging Leaders
10.3.4 Pervasive Players
10.3.5 Participants
Figure 25 Clinical Chemistry Analyzers Market: Competitive Leadership Mapping, 2019
10.4 Competitive Evaluation Matrix for Start-Ups (2019)
10.4.1 Progressive Companies
10.4.2 Starting Blocks
10.4.3 Responsive Companies
10.4.4 Dynamic Companies
Figure 26 Clinical Chemistry Analyzers Market: Competitive Leadership Mapping for Start-Ups, 2019
10.5 Competitive Scenario
10.5.1 Product Launches
Table 100 Key Product Launches
10.5.2 Acquisitions
Table 101 Key Acquisitions
10.5.3 Partnerships, Agreements, and Collaborations
Table 102 Key Partnerships, Agreements, and Collaborations
10.5.4 Expansions
Table 103 Key Expansions

11 Company Profiles
Business Overview, Products Offered, Recent Developments, and Analyst's View
11.1 Roche Diagnostics Ltd.
Figure 27 F. Hoffmann-La Roche Ltd.: Company Snapshot (2019)
11.2 Danaher Corporation
Figure 28 Danaher Corporation: Company Snapshot (2019)
11.3 Abbott Laboratories
Figure 29 Abbott Laboratories: Company Snapshot (2019)
11.4 Thermo Fisher Scientific Inc.
Figure 30 Thermo Fisher Scientific Inc.: Company Snapshot (2019)
11.5 Siemens Healthineers Ag
Figure 31 Siemens Healthineers Ag: Company Snapshot
11.6 Horiba, Ltd.
Figure 32 Horiba Ltd.: Company Snapshot (2019)
11.7 Sysmex Corporation
Figure 33 Sysmex Corporation: Company Snapshot (2019)
11.8 Ekf Diagnostics
Figure 34 Ekf Diagnostics: Company Snapshot
11.9 Hitachi
Figure 35 Hitachi Ltd.: Company Snapshot (2019)
11.10 Ortho Clinical Diagnostics
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.11 Elitechgroup
11.12 Mindray Medical International Ltd.
11.13 Biobase Group
11.14 Sfri Medical Diagnostics
11.15 Trivitron Healthcare Pvt. Ltd.
11.16 Randox Laboratories Ltd.
11.17 Medica Corporation
11.18 Meril Life Sciences Pvt. Ltd.
11.19 Erba Mannheim
11.20 Genrui Biotech Inc.
11.21 Dirui Industrial Co. Ltd.
11.22 Teco Diagnostics
11.23 Balio Diagnostics
11.24 Snibe Co. Ltd.
11.25 Ams Alliance
Details on Business Overview, Products Offered, Recent Developments and Analyst's View Might Not be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights from Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details